Factors associated with treatment interruption in elderly patients with cancer
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: This study was conducted to identify risk factors that predict vulnerability to cancer therapy on the basis of the clinical, geriatric, and quality of life assessment before starting treatment in elderly patients. Methods: Seventy-five patients aged 65 years and over with newly diagnosed stage IV solid cancer receiving chemotherapy were analyzed. Clinical and laboratory data were collected. The geriatric assessment was performed using the Korean versions of the Modified Barthel Index, Instrumental Activities of Daily Living, Mini-Mental State Examination, and Geriatric Depression Scale. The European Organisation for Research and Treatment of Cancer Quality-of-Life Core Questionnaire (EORTC-QLQ-C30) was also performed. Results: Forty-one patients stopped cancer treatment during or after the end of first-line therapy and were classified as the treatment interruption group. By univariate analysis, treatment interruption was associated with metastases to ≥ 2 distant sites, lower albumin level, lower EORTC-QLQ-C30 physical and role functioning scores, and higher EORTC-QLQ-C30 fatigue and appetite loss symptom scores. By multivariate analysis, treatment interruption was significantly associated with low score for the EORTC-QLQ-C30 physical functioning scale (odds ratio [OR], 1.020; 95% confidence interval [CI], 1.002 to 1.039; p = 0.030), and ≥ 2 sites of distant metastases (OR, 2.965; 95% CI, 1.012 to 8.681; p = 0.047). Conclusions: The EORTC-QLQ-C30 physical functioning score and metastases to ≥ 2 organs, which indicate a poor physical functional status and metastatic high tumor burden, were significantly associated with interruption of first-line treatment in elderly patients with cancer.
Abstract
Background/Aims: This study was conducted to identify risk factors that predict vulnerability to cancer therapy on the basis of the clinical, geriatric, and quality of life assessment before starting treatment in elderly patients. Methods: Seventy-five patients aged 65 years and over with newly diagnosed stage IV solid cancer receiving chemotherapy were analyzed. Clinical and laboratory data were collected. The geriatric assessment was performed using the Korean versions of the Modified Barthel Index, Instrumental Activities of Daily Living, Mini-Mental State Examination, and Geriatric Depression Scale. The European Organisation for Research and Treatment of Cancer Quality-of-Life Core Questionnaire (EORTC-QLQ-C30) was also performed. Results: Forty-one patients stopped cancer treatment during or after the end of first-line therapy and were classified as the treatment interruption group. By univariate analysis, treatment interruption was associated with metastases to ≥ 2 distant sites, lower albumin level, lower EORTC-QLQ-C30 physical and role functioning scores, and higher EORTC-QLQ-C30 fatigue and appetite loss symptom scores. By multivariate analysis, treatment interruption was significantly associated with low score for the EORTC-QLQ-C30 physical functioning scale (odds ratio [OR], 1.020; 95% confidence interval [CI], 1.002 to 1.039; p = 0.030), and ≥ 2 sites of distant metastases (OR, 2.965; 95% CI, 1.012 to 8.681; p = 0.047). Conclusions: The EORTC-QLQ-C30 physical functioning score and metastases to ≥ 2 organs, which indicate a poor physical functional status and metastatic high tumor burden, were significantly associated with interruption of first-line treatment in elderly patients with cancer.
참고문헌 (16)
- Kurita GP, "Prevalence and predictors of cognitive dysfunction in opioid-treated patients with cancer : a multinational study", J Clin Oncol, 29, pp.1297~1303 (2011)
- Extermann M, "Predicting the risk of chemotherapy toxicity in older patients : the Chemotherapy Risk Assessment Scale for High-Age Patients(CRASH)score", Cancer, 118, pp.3377~3386 (2012)
- Hurria A, "Predicting chemotherapy toxicity in older adults with cancer : a prospective multicenter study", J Clin Oncol, 29, pp.3457~3465 (2011)
- Wildiers H, "International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer", J Clin Oncol, 32, pp.2595~2603 (2014)
- 정한영, "한글판 수정바델지수(K-MBI)의 개발: 뇌졸중 환자 대상의 다기관 연구", Annals of Rehabilitation Medicine, 31(3), pp.283~297 (2007), 대한재활의학회
- Han C, "An adaptation of the Korean Mini-Mental State Examination(K-MMSE)in elderly Koreans : demographic influence and population-based norms(the AGE study)", Arch Gerontol Geriatr, 47, pp.302~310 (2008)
- Bae JN, "Development of the Korean version of the Geriatric Depression Scale and its short form among elderly psychiatric patients", J Psychosom Res, 57, pp.297~305 (2004)
- Yun YH, "Validation of the Korean version of the EORTC QLQ-C30", Qual Life Res, 13, pp.863~868 (2004)
- Folstein MF, ""Mini-mental state" : a practical method for grading the cognitive state of patients for the clinician", J Psychiatr Res, 12, pp.189~198 (1975)
- Gridelli C, "Treatment of elderly patients with non-small-cell lung cancer : results of an international expert panel meeting of the Italian Association of Thoracic Oncology", Clin Lung Cancer, 16, pp.325~333 (2015)
- Pal SK, "Evaluating the older patient with cancer : understanding frailty and the geriatric assessment", CA Cancer J Clin, 60, pp.120~132 (2010)
- Caillet P, "Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer : ELCAPA study", J Clin Oncol, 29, pp.3636~3642 (2011)
- 정희원, "The Korean version of the FRAIL scale: clinical feasibility and validity of assessing the frailty status of Korean elderly", The Korean Journal of Internal Medicine, 31(3), pp.594~600 (2016), 대한내과학회
- Bozzetti F, "Why the oncologist should consider the nutritional status of the elderly cancer patient", Nutrition, 31, pp.590~593 (2015)
- 정윤화, "Clinical characteristics and outcomes in diffuse large B cell lymphoma patients aged 70 years and older: a single-center experience with a literature review", The Korean Journal of Internal Medicine, 30(5), pp.684~693 (2015), 대한내과학회[DOI]
- Yardley DA, "Visceral disease in patients with metastatic breast cancer : efficacy and safety of treatment with ixabepilone and other chemotherapeutic agents", Clin Breast Cancer, 10, pp.64~73 (2010)